The findings of this study demonstrated that Cytochrome B-245 Beta Chain (CYBB), a major catalytic subunit of NOX, contributed to resistance upon TMZ treatment and altered the sensitivity of mesenchymal GBM to ferroptosis. The gene discussed is CYBB; the disease is glioblastoma.